Please check your internet connection and try again.
## Sodium Phosphate Enema
### Overview
Sodium phosphate enema is a hypertonic saline solution that acts as a saline laxative, drawing water into the colon to stimulate bowel evacuation.
### Primary Indications
* Bowel preparation for diagnostic or surgical procedures.
* Treatment of occasional constipation.
### Adult Dosing
* **Bowel Preparation:** Typically, one 4.5 oz (133 mL) enema administered as a single dose. For some procedures, a second dose may be administered a specified time later per protocol.
* **Constipation:** One 4.5 oz (133 mL) enema administered as a single dose. Not intended for regular or prolonged use.
### Pediatric Dosing
* **Children under 2 years:** Contraindicated.
* **Children 2-5 years:** May require specific product instructions or physician guidance. Limited data on standard dosing. Doses as low as 2.5 oz (75 mL) have been used in some cases, but extreme caution and medical supervision are advised due to risk of electrolyte imbalance.
* **Children 6-11 years:** Typically 2.25 oz (67 mL) to 4.5 oz (133 mL) per day. Administer no more than one dose in 24 hours.
* **Children 12 years and older:** Same as adult dosing.
### Dose Adjustments
No specific dose adjustments are typically required for hepatic or renal impairment, however, caution is warranted, especially in severe impairment, due to the risk of electrolyte disturbances.
### Contraindications
* Congenital megacolon.
* Congestive heart failure.
* Intestinal obstruction or perforation.
* Acute liver failure.
* Anuria.
* Hypersensitivity to sodium phosphate.
* Children under 2 years of age.
* Patients with impaired renal function (may be at increased risk of toxicity).
* Patients with inadequate caloric or fluid intake.
### Adverse Effects
* **Common:** Abdominal cramping, nausea, vomiting, rectal irritation, bloating.
* **Serious:**
* **Hyperphosphatemia, Hypocalcemia, Hypernatremia, Hyponatremia:** Can lead to tetany, seizures, cardiac arrhythmias, and death. Risk is increased in children, elderly, patients with renal impairment, and those with existing electrolyte abnormalities.
* **Dehydration:** Due to fluid shifts.
* **Arrhythmias:** Associated with electrolyte disturbances.
* **Renal tubular damage:** Reported with excessive use.
### Key Drug Interactions
* **Diuretics:** Increased risk of dehydration and electrolyte imbalance.
* **ACE inhibitors/ARBs:** Increased risk of hyperkalemia, especially in renally impaired patients.
* **Drugs affecting renal function (e.g., NSAIDs):** May increase the risk of renal toxicity and electrolyte imbalance.
* **Calcium and magnesium supplements:** May interfere with absorption or be affected by electrolyte shifts.
### Monitoring
* **Electrolytes (phosphate, calcium, sodium, potassium):** Crucial, especially in pediatric patients, elderly, renally impaired, and those with cardiac conditions.
* **Renal function:** Monitor BUN and creatinine, particularly with repeated use or in high-risk individuals.
* **Fluid status:** Assess for signs of dehydration.
### Clinical Pearls
* This product is a hypertonic solution and should be administered slowly and as directed.
* Ensure adequate hydration before and after administration.
* Avoid repeated or prolonged use to prevent electrolyte disturbances and dependence.
* Use with extreme caution in pediatric patients, elderly patients, and those with renal impairment or cardiac disease.
* The maximum daily dose should not be exceeded.
* Consider alternative bowel preparation agents in patients with contraindications or high risk for adverse events.
**Disclaimer:** This information is intended for healthcare professionals. Always consult the most current prescribing information and relevant clinical guidelines before making any treatment decisions.
